High doses drop after moves to curb overprescribing

Patients have been shifting to lower dose PPIs following PBS listing changes, review reveals, but more investigation is needed The Drug Utilisation Sub-Committee (DUSC) of the PBAC has found positive trends in the use of PBS-listed proton pump inhibitor (PPI) medicines following listing changes made to help curb overprescribing. On 1 May 2019, changes were

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous First-gen antihistamine warning
Next Tips for avoiding S8 pitfalls